EDGAR Filing Documents for 0001193125-10-058363

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:

SEC Accession No. 0001193125-10-058363

Filing Date

2010-03-16

Accepted

2010-03-16 16:06:27

Documents

Period of Report

2009-12-31

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 10-K	d10k.htm	10-K	982986
2	DESCRIPTION OF EXECUTIVE INCENTIVE PLAN	dex1061.htm	EX-10.61	2754
3	SUBSIDIARIES OF REGISTRANT	dex211.htm	EX-21.1	1563
4	CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM	dex231.htm	EX-23.1	7894
5	RULE 13A-14(A) CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER	dex311.htm	EX-31.1	9879
6	RULE 13A-14(A) CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER	dex312.htm	EX-31.2	10051
7	SECTION 1350 CERTIFICATION OF PRINCIPAL EXECUTIVE OFFICER	dex321.htm	EX-32.1	4209
8	SECTION 1350 CERTIFICATION OF PRINCIPAL FINANCIAL OFFICER	dex322.htm	EX-32.2	4243
9	GRAPHIC	g39970g73n91.jpg	GRAPHIC	49588
	Complete submission text file	0001193125-10-058363.txt		1093489

Mailing Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125

Business Address 950 TOWER LANE SUITE 900 FOSTER CITY CA 94404-2125 650-358-3456

SCICLONE PHARMACEUTICALS INC (Filer) CIK: 0000880771 (see all company filings)